JP2013511717A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013511717A5 JP2013511717A5 JP2012539940A JP2012539940A JP2013511717A5 JP 2013511717 A5 JP2013511717 A5 JP 2013511717A5 JP 2012539940 A JP2012539940 A JP 2012539940A JP 2012539940 A JP2012539940 A JP 2012539940A JP 2013511717 A5 JP2013511717 A5 JP 2013511717A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- hemoglobin
- binds
- variant
- analyte
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000027455 binding Effects 0.000 claims description 102
- 108010054147 Hemoglobins Proteins 0.000 claims description 59
- 102000001554 Hemoglobins Human genes 0.000 claims description 59
- 238000000034 method Methods 0.000 claims description 58
- 102100021519 Hemoglobin subunit beta Human genes 0.000 claims description 28
- 108091005904 Hemoglobin subunit beta Proteins 0.000 claims description 28
- 239000012491 analyte Substances 0.000 claims description 28
- 102000017011 Glycated Hemoglobin A Human genes 0.000 claims description 5
- 108091005995 glycated hemoglobin Proteins 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 3
- 230000001900 immune effect Effects 0.000 claims 36
- 239000011324 bead Substances 0.000 claims 16
- 239000000975 dye Substances 0.000 claims 13
- 210000000601 blood cell Anatomy 0.000 claims 7
- 239000013592 cell lysate Substances 0.000 claims 7
- 206010012601 diabetes mellitus Diseases 0.000 claims 3
- 238000003018 immunoassay Methods 0.000 claims 3
- 239000008240 homogeneous mixture Substances 0.000 claims 2
- 230000005284 excitation Effects 0.000 claims 1
- 230000036252 glycation Effects 0.000 claims 1
- 230000002452 interceptive effect Effects 0.000 claims 1
- 239000006166 lysate Substances 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 150000001413 amino acids Chemical group 0.000 description 17
- 108090000765 processed proteins & peptides Proteins 0.000 description 16
- 230000002163 immunogen Effects 0.000 description 13
- 235000001014 amino acid Nutrition 0.000 description 12
- 229940024606 amino acid Drugs 0.000 description 12
- 230000009257 reactivity Effects 0.000 description 9
- 238000006467 substitution reaction Methods 0.000 description 8
- 230000003053 immunization Effects 0.000 description 7
- 238000002649 immunization Methods 0.000 description 7
- 102100027685 Hemoglobin subunit alpha Human genes 0.000 description 6
- 108091005902 Hemoglobin subunit alpha Proteins 0.000 description 6
- 108010013766 hemoglobin A(0) Proteins 0.000 description 5
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 239000004472 Lysine Substances 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 125000003588 lysine group Chemical class [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical group NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Chemical group OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Chemical group OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Chemical group 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical group C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical group NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical group OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical group OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical group OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 150000003857 carboxamides Chemical group 0.000 description 1
- 150000007942 carboxylates Chemical group 0.000 description 1
- 230000009137 competitive binding Effects 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Chemical group OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Chemical group OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26248809P | 2009-11-18 | 2009-11-18 | |
| US61/262,488 | 2009-11-18 | ||
| US12/941,738 US8603828B2 (en) | 2009-11-18 | 2010-11-08 | Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms |
| US12/941,738 | 2010-11-08 | ||
| PCT/US2010/055952 WO2011062803A2 (en) | 2009-11-18 | 2010-11-09 | Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015209371A Division JP2016028254A (ja) | 2009-11-18 | 2015-10-23 | ヘモグロビン、ヘモグロビンバリアント、及び糖化フォームの多重免疫アッセイ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013511717A JP2013511717A (ja) | 2013-04-04 |
| JP2013511717A5 true JP2013511717A5 (enExample) | 2013-06-20 |
| JP6139886B2 JP6139886B2 (ja) | 2017-05-31 |
Family
ID=44011571
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012539940A Active JP6139886B2 (ja) | 2009-11-18 | 2010-11-09 | ヘモグロビン、ヘモグロビンバリアント、及び糖化フォームの多重免疫アッセイ |
| JP2015209371A Pending JP2016028254A (ja) | 2009-11-18 | 2015-10-23 | ヘモグロビン、ヘモグロビンバリアント、及び糖化フォームの多重免疫アッセイ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015209371A Pending JP2016028254A (ja) | 2009-11-18 | 2015-10-23 | ヘモグロビン、ヘモグロビンバリアント、及び糖化フォームの多重免疫アッセイ |
Country Status (8)
| Country | Link |
|---|---|
| US (5) | US8603828B2 (enExample) |
| EP (3) | EP3301452B1 (enExample) |
| JP (2) | JP6139886B2 (enExample) |
| AU (3) | AU2010322233B2 (enExample) |
| CA (1) | CA2781255C (enExample) |
| ES (1) | ES2665958T3 (enExample) |
| PT (1) | PT3043182T (enExample) |
| WO (1) | WO2011062803A2 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8603828B2 (en) | 2009-11-18 | 2013-12-10 | Bio-Rad Laboratories, Inc. | Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms |
| US11435358B2 (en) | 2011-06-23 | 2022-09-06 | Board Of Regents, The University Of Texas System | Single molecule peptide sequencing |
| WO2015099123A1 (ja) * | 2013-12-26 | 2015-07-02 | 京セラ株式会社 | センサ |
| WO2015143394A1 (en) * | 2014-03-20 | 2015-09-24 | Bio-Rad Laboratories, Inc. | Glycated protein assay |
| US10288628B2 (en) | 2014-04-11 | 2019-05-14 | Siemens Healthcare Diagnostics Inc. | Spectroscopic methods for the detection of glycated hemoglobin |
| US20160116489A1 (en) * | 2014-10-23 | 2016-04-28 | Biomedomics, Inc. | Lateral flow immunoassay method of simultaneously detecting hemoglobin s, hemoglobin c, and hemoglobin a in newborns, infants, children, and adults |
| US10545158B2 (en) * | 2014-12-29 | 2020-01-28 | North Carolina State University | Multiplexed diagnostic to recognize concentrations of related proteins and peptides |
| CN114923837B (zh) | 2015-02-09 | 2025-09-19 | 弹弓生物科学公司 | 具有可调光学性质的水凝胶颗粒以及使用其的方法 |
| JP6492856B2 (ja) * | 2015-03-25 | 2019-04-03 | 東ソー株式会社 | 安定型糖化ヘモグロビンＡ１ｃの定量方法 |
| EP3365012A1 (en) * | 2015-10-21 | 2018-08-29 | Qoolabs, Inc. | Camelid hemoglobin antibodies and methods of use |
| US10670615B2 (en) | 2015-12-04 | 2020-06-02 | Polymer Technology Systems, Inc. | Systems and methods for interference correction from hemoglobin variants |
| US11091004B2 (en) | 2016-02-17 | 2021-08-17 | Denso Corporation | Air conditioning unit for vehicle |
| US12345718B2 (en) * | 2016-11-04 | 2025-07-01 | Université Paris Est Créteil Val De Marne | Method for determining the haemoglobin content of an erythroid cell |
| US10317413B2 (en) | 2016-11-14 | 2019-06-11 | The Board Of Regents Of The University Of Texas System | Method and kit for detection of anti-zika virus antibodies |
| US11535681B2 (en) * | 2017-12-15 | 2022-12-27 | Bluebird Bio, Inc. | Sickled beta globin antibodies |
| EP3821010A4 (en) | 2018-07-12 | 2022-04-20 | Board of Regents, The University of Texas System | Molecular neighborhood detection by oligonucleotides |
| KR20210068048A (ko) * | 2018-09-28 | 2021-06-08 | 세키스이 메디칼 가부시키가이샤 | 당화 헤모글로빈(％)의 측정 방법 |
| JP2022504225A (ja) | 2018-10-05 | 2022-01-13 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 固相でのｎ末端ペプチド捕捉および解放の方法 |
| EP3942059A4 (en) * | 2019-03-04 | 2022-04-20 | Siemens Healthcare Diagnostics, Inc. | STABILIZATION OF THE SURFACE POLYSACCHARID AREA OF A DRIED REAGENT |
| US20200284807A1 (en) * | 2019-03-05 | 2020-09-10 | Victor Manneh | Saturation binding ratiometric assay |
| CA3165821A1 (en) | 2020-01-24 | 2021-07-29 | Jeffrey Kim | Compositions and methods for cell-like calibration particles |
| EP4147049A1 (en) | 2020-05-04 | 2023-03-15 | Slingshot Biosciences, Inc. | Compositions and methods for passive optical barcoding for multiplexed assays |
| KR20240116721A (ko) | 2021-10-29 | 2024-07-30 | 슬링샷 바이오사이언시즈 인코포레이티드 | 피더 세포 및 합성 항원 제시 세포로서의 하이드로겔 입자 |
| JPWO2023195348A1 (enExample) * | 2022-04-04 | 2023-10-12 | ||
| WO2023196898A1 (en) * | 2022-04-07 | 2023-10-12 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Beta globin mimetic peptides and their use |
| AU2023265684A1 (en) | 2022-05-05 | 2024-11-21 | Slingshot Biosciences, Inc. | Engineered particles as red blood cell mimics and compositions containing same for hematology |
| CN119546284A (zh) | 2022-06-02 | 2025-02-28 | 弹弓生物科学公司 | 凋亡细胞模拟物 |
| EP4608872A2 (en) | 2022-10-26 | 2025-09-03 | Slingshot Biosciences, Inc. | Size-tunable synthetic particles with tunable optical properties and methods for using the same for immune cell activation |
| US12461007B2 (en) | 2023-08-29 | 2025-11-04 | Slingshot Biosciences, Inc. | CD34 stem cell mimics |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2632478A1 (de) | 1975-07-23 | 1977-02-24 | Coulter Electronics | Verfahren zur erfassung und trennung von antigenen und antikoerperchen im blut und in anderen proben |
| US4752583A (en) * | 1984-11-29 | 1988-06-21 | The United States Of America As Represented By The United States Department Of Energy | Monoclonal antibodies to human hemoglobin S and cell lines for the production thereof |
| US5428754A (en) | 1988-03-23 | 1995-06-27 | 3Dlabs Ltd | Computer system with clock shared between processors executing separate instruction streams |
| US5922854A (en) * | 1991-06-14 | 1999-07-13 | Kumar; Ramesh | Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids |
| WO1993018407A1 (en) * | 1992-03-04 | 1993-09-16 | Abbott Laboratories | Determination of glycated hemoglobin by fluorescence quenching |
| US6043043A (en) * | 1993-04-02 | 2000-03-28 | Bayer Corporation | Method for the determination of hemoglobin adducts |
| US6951716B2 (en) * | 1995-03-13 | 2005-10-04 | Mark Hechinger | Anti-platelet immunoglobulin bead positive control |
| US6933106B2 (en) * | 1995-03-13 | 2005-08-23 | Mark Hechinger | Platelet immunoglobulin bead suspension and flow cytometry |
| EP1015028A2 (en) * | 1997-09-19 | 2000-07-05 | Serex, Inc. | Methods to improve immunogenicity of antigens and specificity of antibodies |
| US7271009B1 (en) * | 1997-11-18 | 2007-09-18 | Bio-Rad Laboratories, Inc. | Multi-analyte diagnostic test for thyroid disorders |
| EP0965044B1 (en) * | 1997-11-18 | 2003-03-19 | Bio-Rad Laboratories, Inc. | Multiplex flow immunoassays with magnetic particles as solid phase |
| WO1999064867A1 (en) * | 1997-12-04 | 1999-12-16 | Amersham Pharmacia Biotech Uk Limited | Multiple assay method |
| US20020115116A1 (en) * | 2001-02-22 | 2002-08-22 | Yong Song | Multiplex protein interaction determinations using glutathione-GST binding |
| DE60234933D1 (de) * | 2001-04-26 | 2010-02-11 | Dako Denmark As | Pan-spezifischer monoklonaler antikörper der gegen glycosiliertes hämoglobin gerichtet ist |
| AU2003223520A1 (en) * | 2002-04-12 | 2003-10-27 | Mitokor | Targets for therapeutic intervention identified in the mitochondrial proteome |
| US7326573B2 (en) * | 2003-01-10 | 2008-02-05 | Beckman Coulter, Inc. | Assay procedures and apparatus |
| US20040229284A1 (en) * | 2003-02-19 | 2004-11-18 | The Regents Of The University Of California | Multiplex analysis of proteins |
| US20040214243A1 (en) * | 2003-04-25 | 2004-10-28 | Beckman Coulter, Inc. | Differential determination of hemoglobins |
| US7150995B2 (en) * | 2004-01-16 | 2006-12-19 | Metrika, Inc. | Methods and systems for point of care bodily fluid analysis |
| WO2005116607A1 (en) * | 2004-05-27 | 2005-12-08 | Monash University | A method for the rapid analysis of polypeptides |
| JP2006052480A (ja) | 2004-08-10 | 2006-02-23 | Nisshinbo Ind Inc | セルロース系繊維含有布帛の加工方法及びセルロース系繊維含有布帛 |
| GB0502068D0 (en) * | 2005-02-01 | 2005-03-09 | King S College London | Screening method |
| EP1889906A4 (en) | 2005-06-03 | 2009-06-03 | Nipro Corp | VECTOR WITH HIGH COPY AND HIGH EXPRESSION AND WITH METHIONINAMINOPEPTIDASE GENE INCLUDED |
| US7521244B2 (en) * | 2006-10-26 | 2009-04-21 | Bionostics, Inc. | Standard reference solutions |
| WO2009067421A1 (en) * | 2007-11-20 | 2009-05-28 | Siemens Heathcare Diagnostics Inc. | Methods for the detection of glycated hemoglobin |
| US8260556B2 (en) | 2008-08-21 | 2012-09-04 | Bio-Rad Laboratories, Inc. | Calibration surface method for determination on of analyte ratios |
| CA2765457A1 (en) * | 2009-07-07 | 2011-01-13 | Uvic Industry Partnerships Inc. | Methods for early detection of blood disorders |
| US8603828B2 (en) * | 2009-11-18 | 2013-12-10 | Bio-Rad Laboratories, Inc. | Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms |
-
2010
- 2010-11-08 US US12/941,738 patent/US8603828B2/en active Active
- 2010-11-09 WO PCT/US2010/055952 patent/WO2011062803A2/en not_active Ceased
- 2010-11-09 EP EP17201427.6A patent/EP3301452B1/en active Active
- 2010-11-09 EP EP16155015.7A patent/EP3043182B1/en active Active
- 2010-11-09 PT PT161550157T patent/PT3043182T/pt unknown
- 2010-11-09 EP EP10832004.5A patent/EP2502080B1/en active Active
- 2010-11-09 ES ES16155015.7T patent/ES2665958T3/es active Active
- 2010-11-09 AU AU2010322233A patent/AU2010322233B2/en not_active Ceased
- 2010-11-09 CA CA2781255A patent/CA2781255C/en active Active
- 2010-11-09 JP JP2012539940A patent/JP6139886B2/ja active Active
-
2013
- 2013-11-15 US US14/081,799 patent/US9213034B2/en active Active
-
2015
- 2015-10-23 JP JP2015209371A patent/JP2016028254A/ja active Pending
- 2015-11-20 US US14/947,939 patent/US9605060B2/en active Active
-
2017
- 2017-02-03 AU AU2017200733A patent/AU2017200733B2/en not_active Ceased
- 2017-02-24 US US15/441,455 patent/US10088488B2/en active Active
-
2018
- 2018-09-27 US US16/145,021 patent/US11262366B2/en active Active
-
2019
- 2019-01-07 AU AU2019200070A patent/AU2019200070B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013511717A5 (enExample) | ||
| AU2017200733B2 (en) | Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms | |
| WO2008027942A3 (en) | Combination hepatitis c virus antigen and antibody detection method | |
| EP0602046B2 (en) | Detection of feline immunodeficiency viruses | |
| JPWO2020067396A1 (ja) | 糖化ヘモグロビン（％）の測定方法 | |
| CA2542104A1 (en) | Method for the identification of epitopes related to immunogenicity in biopharmaceuticals | |
| JP4318458B2 (ja) | ｐａｎ特異的モノクローナル抗体 | |
| Watts et al. | Molecular basis for the high degree of antigenic cross-reactivity between hepatitis B virus capsids (HBcAg) and dimeric capsid-related protein (HBeAg): insights into the enigmatic nature of the e-antigen | |
| JP2007526919A5 (enExample) | ||
| CN101928332A (zh) | 一种人hnrpa0多肽及其抗体制备方法 | |
| CN113406240B (zh) | 检测pHLA复合物中抗原肽的超滤-高效液相色谱法 | |
| EP1310512B1 (en) | Hcv core protein sequences | |
| JP2000336099A (ja) | ペプチド及びｃ型肝炎抗体検出用試薬 | |
| AU2021103860A4 (en) | ULTRAFILTRATION-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY METHOD FOR DETECTING ANTIGEN PEPTIDES IN pHLA COMPLEX | |
| Di Placido et al. | Cattle antibodies identify a cross-serotype broadly neutralising foot-and-mouth disease virus epitope | |
| Jin Kang et al. | Enhanced immunodetection of cell-free synthesized erythropoietin under denaturing conditions | |
| RU2008126239A (ru) | Поливалентный химерный вакциноген и диагностический антиген ospc | |
| CN1558237A (zh) | 快速检测尿中的hiv抗体的装置及检测方法 | |
| CN1078805A (zh) | 丙型肝炎检查用试剂及检查方法 | |
| Hu | Structural and immunochemical analysis of the pre-S domains of the hepatitis B surface antigen. |